Gibran Herman
The COVID-19 pandemic necessitated an urgent and accelerated approach to drug development. This abstract highlights the remarkable efforts made in developing drugs for COVID-19, including collaboration among scientists, repurposing existing drugs, and the triumph of vaccine development. The global scientific community joined forces, sharing knowledge and data to understand the virus better. Repurposing existing drugs allowed for faster clinical trials and promising results. The development and distribution of vaccines became a historic achievement, significantly reducing the spread and severity of the virus. Challenges such as safety assessments and equitable distribution were encountered. Lessons learned from this endeavor will shape future drug development and global pandemic preparedness. The COVID-19 drug development race showcases human resilience, scientific advancement, and the power of collaboration.
KeywordsCovid-19; Drug development; Existing drugs
English 
Spanish 
Chinese 
Russian 
French 
Japanese 
Portuguese 
Hindi